We present in three nations
From 22nd to the 25th August we presented papers simultaneously in Stockholm, Sweden, Milan, Italy and Puerto Rico in the Caribbean.
Author: firstimmune
Our 12th paper is on the front page of OncoImmunology
This happens once in a lifetime of research; for a scientist, its like being on the front page of Times Magazine. The paper is called: GC protein-derived macrophage-activating factor decreases a-N-acetylgalactosaminidase levels in advanced cancer patients. Or to translate: GcMAF decreases nagalase in advanced cancer patients. It follows the excellent improvements in 20 cancer patients […]
Professor Marco Ruggiero MD joins us on the 1st November as Consultant Scientific Director
Professor Marco Ruggiero MD joins us on the 1st November as Consultant Scientific Director
Dr Bradstreet has 85% responders, 15% full recoveries, another paper on autism.
Dr Bradstreet has 85% responders, 15% full recoveries, another paper on autism. Read the paper here: http://www.la-press.com/initial-observations-of-elevated-alpha-n-acetylgalactosaminidase-activ-article-a3450-abstract
Mouthwash GcMAF for dentists: diseases of the mouth and sore throat.
GcMAF Mouthwash At the GcMAF Conference 2013 GcMAF announced that it was formally launching Macact Mouthwash. Its principally for dentists to eradicate viral and bacterial diseases of the mouth. It has undergone significant scientific scrutiny and testing. Just one dentist has used it successfully in 10 cases, and it took an average of 8 weeks […]